TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 29101215

Group type: EXPERIMENTAL
Intervention: Man Up documentary
Number of subjects: 337

Group type: COMPARATOR
Intervention: Control documentary
Number of subjects: 337
Study: 27546885

Group type: EXPERIMENTAL
Intervention: Trebananib plus weekly paclitaxel (80mg/m², 3 weeks on/1 week off)
Number of subjects: 919

Group type: COMPARATOR
Intervention: Placebo plus weekly paclitaxel (80mg/m², 3 weeks on/1 week off)
Number of subjects: 919

Group type: EXPERIMENTAL
Intervention: Trebananib plus weekly paclitaxel (80mg/m², 3 weeks on/1 week off) in patients with ascites
Number of subjects: 919

Group type: COMPARATOR
Intervention: Placebo plus weekly paclitaxel (80mg/m², 3 weeks on/1 week off) in patients with ascites
Number of subjects: 919
Study: 24655690

Group type: EXPERIMENTAL
Intervention: Ticagrelor 90 mg twice daily with low dose ASA
Number of subjects: 21000

Group type: EXPERIMENTAL
Intervention: Ticagrelor 60 mg twice daily with low dose ASA
Number of subjects: 21000

Group type: COMPARATOR
Intervention: Matching placebo with low dose ASA
Number of subjects: 21000
Study: 22941233

Group type: EXPERIMENTAL
Intervention: Fast-track surgery
Number of subjects: 47

Group type: COMPARATOR
Intervention: Conventional pathway
Number of subjects: 47
Study: 21121080

Group type: EXPERIMENTAL
Intervention: SLIT with standardized birch pollen allergen extract
Number of subjects: 54

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 54
Study: 17101285

Group type: EXPERIMENTAL
Intervention: Once daily 24 microg formoterol in the morning
Number of subjects: 321

Group type: COMPARATOR
Intervention: Twice daily 12 microg formoterol in the morning and evening
Number of subjects: 321
Study: 16373887

Group type: EXPERIMENTAL
Intervention: Active titration
Number of subjects: 7893

Group type: COMPARATOR
Intervention: Usual titration
Number of subjects: 7893
Study: 14644833

Group type: EXPERIMENTAL
Intervention: SprayGel adhesion barrier prevention
Number of subjects: 51

Group type: COMPARATOR
Intervention: Control (no SprayGel)
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: SprayGel treatment
Number of subjects: 51
Study: 11034574

Group type: EXPERIMENTAL
Intervention: Oral 5‐aminolaevulinic acid (ALA) 30 mg/kg
Number of subjects: 36

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 36
Study: 8836705

Group type: EXPERIMENTAL
Intervention: roxatidine 150 mg
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: ranitidine 300 mg
Number of subjects: 48
Study: 8495155

Group type: EXPERIMENTAL
Intervention: 193 mbar treatment in hyperbaric chamber
Number of subjects: 64

Group type: COMPARATOR
Intervention: 20 mbar control treatment
Number of subjects: 64

Group type: COMPARATOR
Intervention: Bed rest
Number of subjects: 64
Study: 3549829

Group type: EXPERIMENTAL
Intervention: Fluoride dentifrice with 2.0% zinc chloride
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study: 29616825

Group type: EXPERIMENTAL
Intervention: High Treatability Information (HTI)
Number of subjects: 309

Group type: COMPARATOR
Intervention: Low Treatability Information (LTI)
Number of subjects: 309

Group type: COMPARATOR
Intervention: No Information
Number of subjects: 309
Study: 27226183

Group type: EXPERIMENTAL
Intervention: Melatonin supplementation over 90 days
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: Melatonin supplementation
Number of subjects: 102

Group type: COMPARATOR
Intervention: Control group (healthy individuals)
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: RRMS-relapse group
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: Melatonin application
Number of subjects: 102
Study: 24746956

Group type: EXPERIMENTAL
Intervention: Cash-based reinforcement therapy (CBRT)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Voucher-based reinforcement therapy (VBRT)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Non-CM condition
Number of subjects: 0
Study: 23842010

Group type: EXPERIMENTAL
Intervention: Agomelatine (25-50 mg/d by mouth)
Number of subjects: 222

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 222
Study: 20653223

Group type: EXPERIMENTAL
Intervention: Single-color group
Number of subjects: 20

Group type: COMPARATOR
Intervention: Multicolor group
Number of subjects: 20
Study: 17926007

Group type: EXPERIMENTAL
Intervention: RT +/- chemotherapy
Number of subjects: 25

Group type: COMPARATOR
Intervention: No treatment
Number of subjects: 25
Study: 16021014

Group type: EXPERIMENTAL
Intervention: Vertical cages (VCs)
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: Wedged structural allograft (WSA)
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: Threaded cylindrical cages (TCCs)
Number of subjects: 49
Study: 12963676

Group type: EXPERIMENTAL
Intervention: HUD‐VASH with Section 8 vouchers and intensive case management (n = 182)
Number of subjects: 460

Group type: COMPARATOR
Intervention: Case management only (n = 90)
Number of subjects: 460

Group type: COMPARATOR
Intervention: Standard VA care (n = 188)
Number of subjects: 460
Study: 10847258

Group type: EXPERIMENTAL
Intervention: Irbesartan (angiotensin II receptor blocker), once-daily treatment
Number of subjects: 2673

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2673
Study: 8781044

Group type: EXPERIMENTAL
Intervention: High-calcium mineral water (Ferrarelle, Italy)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Low-calcium mineral water
Number of subjects: 45
Study: 1622873

Group type: EXPERIMENTAL
Intervention: Hyperthermic antiblastic perfusion (H.A.P.) followed by surgery alone
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Radiotherapy including protocol
Number of subjects: 80
Study: 4018658

Group type: EXPERIMENTAL
Intervention: Laser vaporization
Number of subjects: 101

Group type: COMPARATOR
Intervention: Cryotherapy
Number of subjects: 101
Study: 31738825

Group type: EXPERIMENTAL
Intervention: Patients with severe MGD
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: Patients with MGD
Number of subjects: 47

Group type: COMPARATOR
Intervention: Control group (participants without MGD)
Number of subjects: 47
Study: 29781089

Group type: EXPERIMENTAL
Intervention: Topical piperine combined with NB‐UVB
Number of subjects: 63

Group type: COMPARATOR
Intervention: Placebo combined with NB‐UVB
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: Topical piperine
Number of subjects: 63
Study: 27138110

Group type: EXPERIMENTAL
Intervention: Behavioral weight loss program (BWL)
Number of subjects: 49

Group type: COMPARATOR
Intervention: Emotional Brain Training (EBT)
Number of subjects: 49
Study: 24895382

Group type: EXPERIMENTAL
Intervention: Hydrotherapy treatment
Number of subjects: 34

Group type: COMPARATOR
Intervention: Land-based rehabilitation treatment
Number of subjects: 34
Study: 22265384

Group type: EXPERIMENTAL
Intervention: Physiotherapists' assessments using the shoulder classification system
Number of subjects: 255

Group type: EXPERIMENTAL
Intervention: Pattern 1 (impingement pain)
Number of subjects: 255

Group type: EXPERIMENTAL
Intervention: Pattern 2 (acromioclavicular joint pain)
Number of subjects: 255

Group type: EXPERIMENTAL
Intervention: Pattern 3 (shoulder pain: frozen shoulder, glenohumeral arthritis, massive cuff tear, subscapularis tear, painful laxity, post‐traumatic instability, internal derangement)
Number of subjects: 255
Study: 20361253

Group type: EXPERIMENTAL
Intervention: Pegylated liposomal doxorubicin (PLD) 40 mg/m(2) every 28 days for six cycles
Number of subjects: 155

Group type: COMPARATOR
Intervention: Observation
Number of subjects: 155
Study: 18851754

Group type: EXPERIMENTAL
Intervention: Multidisciplinary intervention targeting frailty characteristics, functional limitations, nutritional status, falls risk, psychological issues, and management of chronic health conditions.
Number of subjects: 230

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 230
Study: 15756577

Group type: EXPERIMENTAL
Intervention: Mean IOP during the prospective part of the study
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: IOP fluctuations
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Mean IOP level
Number of subjects: 90
Study: 11949773

Group type: EXPERIMENTAL
Intervention: Emedastine 2 mg twice daily
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Emedastine 4 mg twice daily
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Cetirizine 10 mg once daily
Number of subjects: 19

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Alcohol (0.05 g/dl)
Number of subjects: 19
Study: 10085470

Group type: EXPERIMENTAL
Intervention: Capsule A (5 mg MLT)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Capsule B (10 mg MLT)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Capsule C (10 mg MLT)
Number of subjects: 15
Study: 7488780

Group type: EXPERIMENTAL
Intervention: Transmyocardial laser revascularization
Number of subjects: 0
Study: 2206817

Group type: EXPERIMENTAL
Intervention: Body-worn alarm
Number of subjects: 88

Group type: COMPARATOR
Intervention: Traditional pad and bell alarm
Number of subjects: 88

Group type: COMPARATOR
Intervention: Modified dry-bed training
Number of subjects: 88
Study: 88332

Group type: EXPERIMENTAL
Intervention: subliminal conditioning stimuli applied to the ipsilateral posterior tibial nerve
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: subliminal conditioning stimuli applied to the contralateral posterior tibial nerve
Number of subjects: 10
Study: 30522722

Group type: EXPERIMENTAL
Intervention: Initial combination therapy with ambrisentan and tadalafil
Number of subjects: 500

Group type: COMPARATOR
Intervention: Pooled monotherapy
Number of subjects: 500
Study: 27015912

Group type: EXPERIMENTAL
Intervention: Vitamin D3 supplementation (3000 IU daily for 12 weeks via oral spray solution)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 42
Study: 25885424

Group type: EXPERIMENTAL
Intervention: Diuretic dose adjustment according to the AAD and nonpharmacologic management (fluid and sodium restriction) with four telephone calls over 30 days.
Number of subjects: 135

Group type: COMPARATOR
Intervention: Standard diuretic dose adjustment by a physician during the first trial visit without telephone follow-up.
Number of subjects: 135
Study: 24028546

Group type: EXPERIMENTAL
Intervention: 7 weeks delay between RCT and surgery
Number of subjects: 264

Group type: COMPARATOR
Intervention: 11 weeks delay between RCT and surgery
Number of subjects: 264
Study: 21385641

Group type: EXPERIMENTAL
Intervention: Weight loss maintainers (WLM)
Number of subjects: 287
Study: 19409159

Group type: EXPERIMENTAL
Intervention: Band ligation plus propranolol and nitrate
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Propranolol plus isosorbide mononitrate
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Band ligation
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Propranolol
Number of subjects: 160
Study: 17679135

Group type: EXPERIMENTAL
Intervention: Lipid clinic (n=617)
Number of subjects: 1233

Group type: COMPARATOR
Intervention: Standard care (n=616)
Number of subjects: 1233
Study: 15165918

Group type: EXPERIMENTAL
Intervention: Vardenafil 10 mg
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: Sildenafil 50 mg
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: Moxifloxacin 400 mg
Number of subjects: 58

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 58
Study: 11524897

Group type: EXPERIMENTAL
Intervention: Cognitive behavior therapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Pharmacotherapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Psychosocial interventions
Number of subjects: 0
Study: 9735580

Group type: EXPERIMENTAL
Intervention: Behavior therapy with initial weight loss
Number of subjects: 130

Group type: EXPERIMENTAL
Intervention: Behavior therapy with weight-loss goals
Number of subjects: 130

Group type: EXPERIMENTAL
Intervention: Behavior therapy with achieved weight goals
Number of subjects: 130

Group type: EXPERIMENTAL
Intervention: Behavior therapy
Number of subjects: 130
Study: 7817735

Group type: EXPERIMENTAL
Intervention: Medical abortion (mifepristone 600 mg followed 48 h later by gemeprost 1 mg vaginal pessary)
Number of subjects: 363

Group type: COMPARATOR
Intervention: Surgical vacuum aspiration under general anesthesia
Number of subjects: 363
Study: 3186088

Group type: EXPERIMENTAL
Intervention: 500 mg ampicillin orally every 6 hours for 10 days
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: 500 mg erythromycin orally every 6 hours for 10 days
Number of subjects: 150

Group type: COMPARATOR
Intervention: Control group (no antibiotics)
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Positive amniotic fluid cultures
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Negative amniotic fluid cultures
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Histologic chorioamnionitis in negative cultures
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Cervical colonization with group B streptococcus and/or Gardnerella vaginalis
Number of subjects: 150
Study: 51533

Group type: EXPERIMENTAL
Intervention: Candicidin therapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 31530204

Group type: EXPERIMENTAL
Intervention: Peer assessment platform of clinical skills (Year 2013 students)
Number of subjects: 252

Group type: COMPARATOR
Intervention: Traditional training (Year 2012 students)
Number of subjects: 252
Study: 28323989

Group type: EXPERIMENTAL
Intervention: Low-dose aspirin (81 mg)
Number of subjects: 1228

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1228
Study: 25474502

Group type: EXPERIMENTAL
Intervention: Core-Stability (CS) exercises plus myofascial trigger-point (MTrP) therapy
Number of subjects: 10

Group type: COMPARATOR
Intervention: Core-Stability (CS) exercises alone
Number of subjects: 10
Study: 23299139

Group type: EXPERIMENTAL
Intervention: Intermittent pneumatic compression (IPC) using calf-thigh-length IPC in both legs (SCD Express)
Number of subjects: 56

Group type: COMPARATOR
Intervention: No IPC (control group)
Number of subjects: 56
Study: 21624223

Group type: EXPERIMENTAL
Intervention: Dexamethasone (HD-DXM)
Number of subjects: 59

Group type: COMPARATOR
Intervention: Prednisone
Number of subjects: 59
Study: 18424874

Group type: EXPERIMENTAL
Intervention: Residential treatment
Number of subjects: 0

Group type: COMPARATOR
Intervention: Day hospital
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Comparison of both interventions
Number of subjects: 0
Study: 17112374

Group type: EXPERIMENTAL
Intervention: Acupuncture treatment
Number of subjects: 1345

Group type: EXPERIMENTAL
Intervention: Consultation with a GP who offers acupuncture
Number of subjects: 1345

Group type: EXPERIMENTAL
Intervention: Consultation with a specialist
Number of subjects: 1345

Group type: EXPERIMENTAL
Intervention: Chronic back pain
Number of subjects: 1345
Study: 14768525

Group type: EXPERIMENTAL
Intervention: Nimesulide
Number of subjects: 381

Group type: EXPERIMENTAL
Intervention: Meloxicam
Number of subjects: 381
Study: 11155022

Group type: EXPERIMENTAL
Intervention: Acupuncture massage (APM)
Number of subjects: 109

Group type: COMPARATOR
Intervention: Swedish massage (SM)
Number of subjects: 109

Group type: EXPERIMENTAL
Intervention: Individual medical exercises (IE)
Number of subjects: 109

Group type: COMPARATOR
Intervention: Group exercises (GE)
Number of subjects: 109
Study: 9096993

Group type: EXPERIMENTAL
Intervention: Somatulin (30 mg) administered via intramuscular injections every 10 days for 9 months
Number of subjects: 9

Group type: COMPARATOR
Intervention: Placebo administered via intramuscular injections every 10 days for 9 months
Number of subjects: 9
Study: 1491545

Group type: EXPERIMENTAL
Intervention: Home care for 30 patients living within an hour of the hospital for three months post discharge
Number of subjects: 163

Group type: EXPERIMENTAL
Intervention: Home care for 30 patients
Number of subjects: 163
Study: 2883818

Group type: EXPERIMENTAL
Intervention: Temazepam 20 mg
Number of subjects: 32

Group type: COMPARATOR
Intervention: Flunitrazepam 2 mg
Number of subjects: 32
Study: 31412056

Group type: EXPERIMENTAL
Intervention: Motor imagery practice (MIp): 15 minutes per day, 5 days per week in addition to routine physical therapy
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Motor imagery practice (MIp)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Control group (CON): routine physical therapy alone
Number of subjects: 34
Study: 30280915

Group type: EXPERIMENTAL
Intervention: Music
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Stress Ball
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Video
Number of subjects: 120

Group type: COMPARATOR
Intervention: Control
Number of subjects: 120
Study: 27295868

Group type: EXPERIMENTAL
Intervention: Experimental toothpaste containing 5% calcium sodium phosphosilicate (CSPS)
Number of subjects: 137

Group type: COMPARATOR
Intervention: Abrasivity-matched placebo formulation (0% CSPS)
Number of subjects: 137

Group type: COMPARATOR
Intervention: Commercially available fluoride toothpastes (controls)
Number of subjects: 137

Group type: EXPERIMENTAL
Intervention: Dentine Hypersensitivity Experience Questionnaire (DHEQ)
Number of subjects: 137
Study: 24746570

Group type: EXPERIMENTAL
Intervention: Forward planned field-in-field IMRT
Number of subjects: 815

Group type: COMPARATOR
Intervention: Standard RT
Number of subjects: 815
Study: 23185549

Group type: EXPERIMENTAL
Intervention: neoprene knee sleeve
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: knee sleeve with four bilateral metal supports
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: prophylactic knee brace
Number of subjects: 31

Group type: COMPARATOR
Intervention: nonbraced (control)
Number of subjects: 31
Study: 20965118

Group type: EXPERIMENTAL
Intervention: Cognitive Behavioural Therapy (CBT)
Number of subjects: 95

Group type: COMPARATOR
Intervention: Sertraline
Number of subjects: 95

Group type: COMPARATOR
Intervention: Guided Self-Help Group (GSG)
Number of subjects: 95
Study: 17511229

Group type: EXPERIMENTAL
Intervention: Proton-pump inhibitors (PPIs)
Number of subjects: 0

Group type: COMPARATOR
Intervention: H2-receptor antagonists (H2RAs)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: On-demand treatment with H2RA
Number of subjects: 0
Study: 16334718

Group type: EXPERIMENTAL
Intervention: Acupuncture and mild moxibustion
Number of subjects: 200

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 200
Study: 12456911

Group type: EXPERIMENTAL
Intervention: Intranasal flunisolide therapy (200 micro g twice a day)
Number of subjects: 183
Study: 10480618

Group type: EXPERIMENTAL
Intervention: Acetoacetate (AA) treatment in normal RBCs (37 degrees C for 24 h)
Number of subjects: 0

Group type: COMPARATOR
Intervention: BHB treatment in normal RBCs
Number of subjects: 0

Group type: COMPARATOR
Intervention: ACE treatment in normal RBCs
Number of subjects: 0

Group type: COMPARATOR
Intervention: BHB presence with AA
Number of subjects: 0

Group type: COMPARATOR
Intervention: Vitamin E and N-acetylcysteine (NAC) as antioxidants
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Hyperketonemic diabetic patients
Number of subjects: 0

Group type: COMPARATOR
Intervention: Normoketonemic type 1 diabetic patients
Number of subjects: 0
Study: 8729596

Group type: EXPERIMENTAL
Intervention: Diskus inhaler
Number of subjects: 159

Group type: COMPARATOR
Intervention: Turbuhaler inhaler
Number of subjects: 159
Study: 1365044

Group type: EXPERIMENTAL
Intervention: Pineal calcification (PC) on CT scan
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Disturbances of melatonin secretion
Number of subjects: 0
Study: 7135289

Group type: EXPERIMENTAL
Intervention: Low-pressure, high-volume type of cuff
Number of subjects: 28

Group type: COMPARATOR
Intervention: Traditional high-pressure, low-volume type of cuff
Number of subjects: 28
Study: 31800067

Group type: EXPERIMENTAL
Intervention: Use of β‐blockers
Number of subjects: 1761
Study: 30043453

Group type: EXPERIMENTAL
Intervention: Generalised periodontitis
Number of subjects: 804

Group type: EXPERIMENTAL
Intervention: 1-10 remaining teeth
Number of subjects: 804

Group type: COMPARATOR
Intervention: ≥21 remaining teeth
Number of subjects: 804
Study: 26477698

Group type: EXPERIMENTAL
Intervention: Rosuvastatin 10 mg daily
Number of subjects: 147

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 147
Study: 25140337

Group type: EXPERIMENTAL
Intervention: Tunneled epidural catheters
Number of subjects: 121

Group type: COMPARATOR
Intervention: Taped epidural catheters
Number of subjects: 121
Study: 22203319

Group type: EXPERIMENTAL
Intervention: Methylphenidate (MPH) 0.3 mg/kg
Number of subjects: 23
Study: 20004291

Group type: EXPERIMENTAL
Intervention: Milnacipran (MLN)
Number of subjects: 195

Group type: EXPERIMENTAL
Intervention: Venlafaxine (VLF)
Number of subjects: 195
Study: 17175163

Group type: EXPERIMENTAL
Intervention: Fissureless technique
Number of subjects: 63

Group type: COMPARATOR
Intervention: Traditional technique
Number of subjects: 63
Study: 16356093

Group type: EXPERIMENTAL
Intervention: Antithyroid drugs
Number of subjects: 179

Group type: EXPERIMENTAL
Intervention: Radioiodine
Number of subjects: 179

Group type: EXPERIMENTAL
Intervention: Surgery
Number of subjects: 179

Group type: EXPERIMENTAL
Intervention: Young medical patients (<35 years)
Number of subjects: 179

Group type: EXPERIMENTAL
Intervention: Older surgical and radioiodine groups
Number of subjects: 179

Group type: COMPARATOR
Intervention: All treatment groups
Number of subjects: 179

Group type: COMPARATOR
Intervention: Young medical, young surgical, and older medical groups
Number of subjects: 179
Study: 11895556

Group type: EXPERIMENTAL
Intervention: 20 microg vaccine (Genhevac-B)
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Combination of 20 microg vaccine (Genhevac-B) and 9 MU interferon alpha-2b (Roferon-A)
Number of subjects: 25
Study: 9469336

Group type: EXPERIMENTAL
Intervention: r-metHu granulocyte colony-stimulating factor (G-CSF) during continuation therapy
Number of subjects: 89

Group type: COMPARATOR
Intervention: Control group (no G-CSF) during induction phase
Number of subjects: 89

Group type: COMPARATOR
Intervention: Control group (no G-CSF) during continuation therapy
Number of subjects: 89
Study: 17214176

Group type: EXPERIMENTAL
Intervention: Human lymphoblastoid IFN alpha (Wellferon‐R) at a dosage of 5 MU, thrice weekly for 4 months
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group (no treatment)
Number of subjects: 60
Study: 2193849

Group type: EXPERIMENTAL
Intervention: 0.1-s PRP
Number of subjects: 43

Group type: COMPARATOR
Intervention: 0.5-s PRP
Number of subjects: 43
Study: 763184

Group type: EXPERIMENTAL
Intervention: De-Nol
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: cimetidine
Number of subjects: 60
Study: 31058733

Group type: EXPERIMENTAL
Intervention: Altered scheduling of home care visits (n = 35)
Number of subjects: 67

Group type: COMPARATOR
Intervention: Usual care (control group, n = 32)
Number of subjects: 67
Study: 29070134

Group type: EXPERIMENTAL
Intervention: CDT+AC
Number of subjects: 139

Group type: COMPARATOR
Intervention: AC
Number of subjects: 139